Article
Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care Biobank.
Circulation. Genomic and precision medicine - 1 Jun 2026
Xu Jianfeng, Shi Zhuqing, Khetarpal Sumeet A, Mulford Ashley J, Siddiqui Osama, Tran Huy, Wei Jun, Ashworth Annabelle, Zheng S Lilly, Duggan David, Helfand Brian T, Dunnenberger Henry M, Hulick Peter J, Davidson David J, Khera Amit V, Patel Aniruddh P, Sanders Alan R, Qamar Arman
Abstract excerpt
BACKGROUND: Current genetic testing for coronary artery disease (CAD) primarily targets monogenic variants in individuals with severe hypercholesterolemia. Whether supplementing monogenic testing with polygenic risk scores for CAD and Lp(a; lipoprotein[a]) levels [PRSLp(a)] improves identification of high-risk individuals in the general population remains understudied. METHODS: A genetic probability for CAD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
